When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 20 Mar 2025
Last updated: 25 Aug 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • fever (≥37.5°C)
  • flu-like symptoms
  • paraesthesias
  • hyperaesthesias
  • severe persistent headache
  • dizziness
  • ocular pain
  • gait disturbances
  • ataxia
  • diplopia
  • agitation
  • meningismus
  • muscle weakness (paresis)
  • persistent hiccups
  • dyspnoea
  • ascending or acute flaccid paralysis
  • vesicular lesions

Other diagnostic factors

  • nausea/vomiting
  • conjunctivitis
  • rash
  • lymphadenitis
  • lymphangitis
  • abdominal pain

Risk factors

  • occupational exposure
  • travel to countries with free-roaming macaques
  • keeping macaques as pets
  • exposure to non-macaque species that have been housed with macaques

Diagnostic investigations

1st investigations to order

  • serology
  • polymerase chain reaction (PCR)

Investigations to consider

  • viral culture
  • brain MRI
  • brain CT
  • CSF tests
  • EEG
  • brainstem auditory evoked responses
  • somatosensory evoked potentials
  • laboratory testing of animal specimen

Treatment algorithm

Contributors

Authors

Richard Whitley, MD

Professor of Pediatrics

Professor of Microbiology, Medicine, and Neurosurgery

University of Alabama

Birmingham

AL

Disclosures

RW is a retired Board Member for Gilead Sciences, Inc., and a current member of Scientific Advisory Boards or Data Management Committees for Clear Creek Biosciences, Merck, Virios Therapeutics, Visby Medical, Evrys BioSciences, Enochian Biosciences, and Leyden Laboratories.

Acknowledgements

Professor Richard Whitley would like to gratefully acknowledge Dr D. Scott Schmid, Dr Jeffrey I. Cohen, and Dr Louisa E. Chapman, previous contributors to this topic, and Dr Julia K. Hilliard for her contributions to this topic. Unfortunately, we have been made aware that Dr Louisa E. Chapman is now deceased.

Disclosures

JKH, JIC, and LEC are the authors of several references cited in this topic. DSS declared that he had no competing interests. The views included in this topic are those of the authors (DSS and JIC) and do not necessarily represent the views of the Centers for Disease Control and Prevention or the National Institutes of Health.

Peer reviewers

Anna Maria Geretti, MD, PhD, FRCPath

Professor of Virology and Infectious Diseases

University of Liverpool

Liverpool

UK

Disclosures

AMG declares that she has no competing interests.

Deanna Saylor, MD, MHS

Assistant Professor of Neurology

Johns Hopkins University School of Medicine

Baltimore

MD

Disclosures

DS has received research funding from the National Institutes of Health, the World Federation of Neurology, and the Johns Hopkins Center for AIDS Research.

Use of this content is subject to our disclaimer